In fact, previous meta‐analyses were not performed separately for different histological types of NSCLC, and the results in different subgroups did not agree, possibly suggesting that the insufficiently robust prognostic performance of Ki67 observed in the clinical practice of NSCLC might be associated with the biological heterogeneity of different histological types. The gene discussed is MKI67; the disease is non-small cell lung carcinoma.